Author Correction: Targeted pharmacological therapy restores β-cell function for diabetes remission.

Saved in:
Bibliographic Details
Title: Author Correction: Targeted pharmacological therapy restores β-cell function for diabetes remission.
Authors: Sachs S; Institute of Diabetes and Regeneration Research, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany.; Institute of Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany.; Division of Metabolic Diseases, Department of Medicine, Technical University of Munich, Munich, Germany.; German Center for Diabetes Research (DZD), Neuherberg, Germany., Bastidas-Ponce A; Institute of Diabetes and Regeneration Research, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany.; German Center for Diabetes Research (DZD), Neuherberg, Germany.; Institute of Stem Cell Research, Helmholtz Center Munich, Neuherberg, Germany.; Department of Medicine, Technical University of Munich, Munich, Germany., Tritschler S; Institute of Diabetes and Regeneration Research, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany.; German Center for Diabetes Research (DZD), Neuherberg, Germany.; Institute of Computational Biology, Helmholtz Center Munich, Neuherberg, Germany.; School of Life Sciences Weihenstephan, Technical University of Munich, Freising, Germany., Bakhti M; Institute of Diabetes and Regeneration Research, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany.; German Center for Diabetes Research (DZD), Neuherberg, Germany.; Institute of Stem Cell Research, Helmholtz Center Munich, Neuherberg, Germany., Böttcher A; Institute of Diabetes and Regeneration Research, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany.; German Center for Diabetes Research (DZD), Neuherberg, Germany.; Institute of Stem Cell Research, Helmholtz Center Munich, Neuherberg, Germany., Sánchez-Garrido MA; Institute of Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany., Tarquis-Medina M; Institute of Diabetes and Regeneration Research, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany.; German Center for Diabetes Research (DZD), Neuherberg, Germany.; Institute of Stem Cell Research, Helmholtz Center Munich, Neuherberg, Germany.; Department of Medicine, Technical University of Munich, Munich, Germany., Kleinert M; Institute of Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany.; Section of Molecular Physiology, Department of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark., Fischer K; Institute of Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany.; Division of Metabolic Diseases, Department of Medicine, Technical University of Munich, Munich, Germany., Jall S; Institute of Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany.; Division of Metabolic Diseases, Department of Medicine, Technical University of Munich, Munich, Germany., Harger A; Institute of Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany., Bader E; Institute of Diabetes and Regeneration Research, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany., Roscioni S; Institute of Diabetes and Regeneration Research, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany., Ussar S; German Center for Diabetes Research (DZD), Neuherberg, Germany.; Department of Medicine, Technical University of Munich, Munich, Germany.; RG Adipocytes & Metabolism, Institute for Diabetes & Obesity, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany., Feuchtinger A; Research Unit Analytical Pathology, Helmholtz Center Munich, Neuherberg, Germany., Yesildag B; InSphero AG, Schlieren, Switzerland., Neelakandhan A; InSphero AG, Schlieren, Switzerland., Jensen CB; Global Drug Discovery, Novo Nordisk A/S, Maaloev, Denmark., Cornu M; Global Drug Discovery, Novo Nordisk A/S, Maaloev, Denmark., Yang B; Novo Nordisk Research Center Indianapolis, Indianapolis, IN, USA., Finan B; Novo Nordisk Research Center Indianapolis, Indianapolis, IN, USA., DiMarchi RD; Novo Nordisk Research Center Indianapolis, Indianapolis, IN, USA.; Department of Chemistry, Indiana University, Bloomington, IN, USA., Tschöp MH; Institute of Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany.; Division of Metabolic Diseases, Department of Medicine, Technical University of Munich, Munich, Germany.; German Center for Diabetes Research (DZD), Neuherberg, Germany., Theis FJ; Institute of Computational Biology, Helmholtz Center Munich, Neuherberg, Germany. fabian.theis@helmholtz-muenchen.de.; School of Life Sciences Weihenstephan, Technical University of Munich, Freising, Germany. fabian.theis@helmholtz-muenchen.de.; Department of Mathematics, Technical University of Munich, Munich, Germany. fabian.theis@helmholtz-muenchen.de., Hofmann SM; Institute of Diabetes and Regeneration Research, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany. susanna.hofmann@helmholtz-muenchen.de.; German Center for Diabetes Research (DZD), Neuherberg, Germany. susanna.hofmann@helmholtz-muenchen.de.; Medical Clinic and Polyclinic IV, Ludwig Maximilian University of Munich, Munich, Germany. susanna.hofmann@helmholtz-muenchen.de., Müller TD; Institute of Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany. timo.mueller@helmholtz-muenchen.de.; German Center for Diabetes Research (DZD), Neuherberg, Germany. timo.mueller@helmholtz-muenchen.de.; Department of Pharmacology and Experimental Therapy, Institute of Experimental and Clinical Pharmacology and Toxicology, Eberhard Karls University Hospitals and Clinics, Tübingen, Germany. timo.mueller@helmholtz-muenchen.de., Lickert H; Institute of Diabetes and Regeneration Research, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany. heiko.lickert@helmholtz-muenchen.de.; German Center for Diabetes Research (DZD), Neuherberg, Germany. heiko.lickert@helmholtz-muenchen.de.; Institute of Stem Cell Research, Helmholtz Center Munich, Neuherberg, Germany. heiko.lickert@helmholtz-muenchen.de.; Department of Medicine, Technical University of Munich, Munich, Germany. heiko.lickert@helmholtz-muenchen.de.
Source: Nature metabolism [Nat Metab] 2020 Apr; Vol. 2 (4), pp. 380.
Publication Type: Published Erratum
Journal Info: Publisher: Springer Nature Country of Publication: Germany NLM ID: 101736592 Publication Model: Print Cited Medium: Internet ISSN: 2522-5812 (Electronic) Linking ISSN: 25225812 NLM ISO Abbreviation: Nat Metab Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2522-5812
DOI:10.1038/s42255-020-0201-1